Differences in treatment goals and perception of symptom burden between patients with myeloproliferative neoplasms (MPNs) and hematologists/oncologists in the United States: Findings from the MPN Landmark survey.
about
Variables associated with patient-reported outcomes in persons with chronic myeloid leukemia receiving tyrosine kinase-inhibitor therapy.Prevalence of Physical Problems Detected by the Distress Thermometer and Problem List in Patients With Myeloproliferative Disorders.Prognostication and Initiation of Therapy in Polycythemia Vera: Do We Have it Right?
P2860
Differences in treatment goals and perception of symptom burden between patients with myeloproliferative neoplasms (MPNs) and hematologists/oncologists in the United States: Findings from the MPN Landmark survey.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Differences in treatment goals ...... from the MPN Landmark survey.
@en
Differences in treatment goals ...... h myeloproliferative neoplasms
@nl
type
label
Differences in treatment goals ...... from the MPN Landmark survey.
@en
Differences in treatment goals ...... h myeloproliferative neoplasms
@nl
prefLabel
Differences in treatment goals ...... from the MPN Landmark survey.
@en
Differences in treatment goals ...... h myeloproliferative neoplasms
@nl
P2093
P2860
P356
P1433
P1476
Differences in treatment goals ...... from the MPN Landmark survey.
@en
P2093
Ahmad Naim
Carole B Miller
David G Dubinski
Dilan C Paranagama
James Mangan
John Boyle
John O Mascarenhas
Maureen Thyne
Ruben A Mesa
Salman Fazal
P2860
P304
P356
10.1002/CNCR.30325
P407
P577
2016-09-30T00:00:00Z